FMP
Reneo Pharmaceuticals, Inc.
RPHM
NASDAQ
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
1.65 USD
-0.03 (-1.82%)
About
ceo
Mr. Gregory J. Flesher
sector
Healthcare
industry
Biotechnology
website
https://reneopharma.com
exchange
NASDAQ
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. Reneo Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
CIK
0001637715
ISIN
US75974E1038
CUSIP
75974E103
Address
18575 Jamboree Road
Phone
619 733 3852
Country
US
Employee
55
IPO Date
Apr 8, 2021
Summary
CIK
0001637715
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
75974E103
ISIN
US75974E1038
Country
US
Price
1.65
Beta
0.24
Volume Avg.
199.96k
Market Cap
54.96M
Shares
-
52-Week
0.98-10.98
DCF
0.75
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.7
P/B
-
Website
https://reneopharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest RPHM News
It looks like there's no news available.
